First Hepatitis C Settlements Reached In Japan Prefectures
This article was originally published in PharmAsia News
The first cases of hepatitis C suits filed against the government have been settled in Japan's prefectures of Fukuoka and Osaka, with 29 plaintiffs agreeing to government-proposed compensation. Damage suits filed against drug makers such as Mitsubishi Tanabe Pharma for selling tainted blood that caused fatal liver ailments in Japanese patients remain in play. Negotiations by the 29, who were among about 240 people to file suit as far back as 2002, are not expected to be held with the drug makers. The government also is considering plans to offer help for hepatitis B and C patients not covered by a law passed last month to enable the settlements. (Click here for more
You may also be interested in...
Demand for tele-diagnostic tools has reached unprecedented levels during COVID-19, said Kees Wesdrop, Royal Philips’ chief business leader of precision diagnosis.
Transparency On COVID Vaccine Clinical Holds Needed, Sharfstein Says; US FDA Advisory Cmtes Offer Venue
Former acting Commissioner Josh Sharfstein argues that while agency officials have done a commendable job in overall communication on COVID vaccine development, more information is needed on the clinical holds.
Trump administration effort to reduce drug prices by curtailing agency program requiring new approvals for some old products undermines FDA’s role in policing the safety of prescription drugs, experts say.